Dimemebfe

Source: Wikipedia, the free encyclopedia.
Dimemebfe
Clinical data
Other names5-MeO-BFE
Legal status
Legal status
  • DE: NpSG (Industrial and scientific use only)
  • UK: Class A
  • US: Unscheduled and not FDA approved
Identifiers
  • 2-(5-Methoxy-1-benzofuran-3-yl)-N,N-dimethylethanamine
JSmol)
  • CN(C)CCc1coc(c1c2)ccc2OC
  • InChI=1S/C13H17NO2/c1-14(2)7-6-10-9-16-13-5-4-11(15-3)8-12(10)13/h4-5,8-9H,6-7H2,1-3H3 ☒N
  • Key:WBPQJTBOQCCTFX-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

Dimemebfe (5-MeO-BFE) is a

serotonin agonist than 5-MeO-DMT and with relatively more activity at 5-HT1A, but still shows strongest effects at the 5-HT2 family of receptors.[2]

Legal status

Dimemebfe is a Schedule I controlled substance in the US state of Alabama.[3]

See also

References

  1. ^ Casale JF, Hays PA. "The Characterization of 2-(5-Methoxy-1-benzofuran-3-yl)-N,N-dimethylethanamine (5-MeO-BFE) and Differentiation from its N-Ethyl Analog" (PDF). Microgram Journal. 9 (1): 39–45. Archived from the original (PDF) on 2017-05-13. Retrieved 2015-02-23.
  2. PMID 1534585
    .
  3. ^ "Alabama Senate Bill 333 - Controlled substances, Schedule I, additional synthetic controlled substances and analogue substances included in, trafficking in controlled substance analogues, requisite weight increased, Secs. 13A-12-231, 20-2-23 am'd". March 2014. Retrieved 28 September 2015.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Dimemebfe&oldid=1202017879"